Drug intelligence / Profile preview

Comfort Drops

Development stage: Unknown
Lead developer: CooperVision
Modality: Classical Binding Small Molecules → Small Molecules, Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Ophthalmic

Overview

"Comfort Drops" refers to a brand of artificial tears, which are ophthalmic solutions designed to provide relief and hydration for dry, irritated eyes. These drops are often suitable for use with contact lenses and help alleviate discomfort caused by environmental factors like wind, dust, air conditioning, or prolonged screen use. They function by lubricating the ocular surface and temporarily supplementing the natural tear film to improve tear film stability and volume.

Brand names: Comfort DropsREFRESH CONTACTS® Contact Lens Comfort DropsACS Comfort Eye DropsBausch & Lomb Sensitive Eyes Comfort Drops

Beyond the preview

Go deeper on Comfort Drops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Comfort Drops.

Explore the full profile